-
Federal
Inhaled nitric oxide in acute respiratory distress syndrome with and without septic shock requiring norepinephrine administration: a dose–response study
U.S. Department of Health & Human Services —
Background: The aim of this prospective study was to assess whether the presence of septic shock could influence the dose response to inhaled nitric oxide (NO) in NO-... -
Federal
Inhaled nitric oxide in persistent pulmonary hypertension of the newborn refractory to high-frequency ventilation
U.S. Department of Health & Human Services —
Background: This study was designed to evaluate the effect of nitric oxide (NO) on the management of neonates with severe persistent pulmonary hypertension refractory... -
Federal
Inhaled nitric oxide reverses cell-free hemoglobin-induced pulmonary hypertension and decreased lung compliance. Preliminary results
U.S. Department of Health & Human Services —
Background: In order to test the hypothesis that inhaled nitric oxide (NO) reverses the pulmonary hypertension induced by αα-diaspirin crosslinked hemoglobin (ααHb),... -
Federal
Equipment review: Pulmonary uptake and modes of administration of inhaled nitric oxide in mechanically-ventilated patients
U.S. Department of Health & Human Services —
Equipment review: Pulmonary uptake and modes of administration of inhaled nitric oxide in mechanically-ventilated patients -
Federal
Acute hemodynamic effects of inhaled nitric oxide, dobutamine and a combination of the two in patients with mild to moderate secondary pulmonary hypertension
U.S. Department of Health & Human Services —
Introduction The use of low-dose dobutamine to maintain hemodynamic stability in pulmonary hypertension may have a detrimental effect on gas exchange. The aim of this...